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Background: The potential role of fungal organisms and their co-aggregation with either periodontopathogens or
opportunistic pathogens at peri-implantitis sites is unknown. The aim of the present study was to qualitatively/
quantitatively analyze and correlate fungal organisms and bacterial species at peri-implantitis sites.
Methods: In a total of 29 patients, submucosal/subgingival plaque samples were collected at peri-implantitis and
healthy implant sites as well as teeth with a history of periodontitis (controls). A real-time PCR assay was established
for the qualification of fungal organisms and a TaqMan assay for the quantification of Porphyromonas gingivalis,
Parvimonas micra, Tannerella forsythia, Mycoplasma salivarium, Veillonella parvula, and Staphylococcus aureus.
Results: Fungal organisms were more frequently identified at peri-implantitis (31.6%) (i.e., Candida albicans, Candida
boidinii, Penicillium spp., Rhodotorula laryngis, Paelicomyces spp., Saccharomycetes, Cladosporium cladosporioides) and
healthy implant sites (40% - Candida dubliniensis, C. cladosporioides) than at selected teeth (20% - C. albicans,
Fusarium solani). At implant sites, fungal organisms were significantly correlated with P. micra and T. forsythia.
Conclusions: Candida spp. and other fungal organisms were frequently identified at peri-implantitis as well as
healthy implant sites and co-colonized with P. micra and T. forsythia.
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There is considerable evidence supporting the view that
peri-implant diseases are infectious in nature and mainly
linked to an uncontrolled accumulation of bacterial
plaque biofilms [1]. Basically, diseased implant sites are
dominated by gram-negative anaerobic bacteria and
therefore feature microbiological characteristics similar
to those noted for chronic periodontal infections [2].
Even though the history of periodontitis is a documented
risk indicator for peri-implant diseases [3,4], the diver-
sity of microbiota at diseased tooth sites was reported to
be higher than that noted at diseased implant sites [5].
Common periodontopathogenic bacteria could be iso-
lated at both healthy and diseased implant sites [6], and
the microbiological analysis of 40 species did not mark-
edly differ by the clinical implant status (i.e., healthy,
mucositis, peri-implantitis) [7]. However, a most recent
analysis of 78 species has pointed to higher counts of 19* Correspondence: kathrin.becker@med.uni-dueseldorf.de
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in any medium, provided the original work is pbacterial species at peri-implantitis - when compared
with healthy implant sites, mainly including Porphyro-
monas gingivalis (P. gingivalis) and Tannerella forsythia
(T. forsythia) [4].
In addition, peri-implantitis was linked with opportun-
istic pathogens such as Pseudomonas aeruginosa and
Staphylococcus aureus (S. aureus), thus pointing to a ra-
ther complex and heterogenous ‘polymicrobal infection’.
Yeasts are frequently isolated from the oral cavity [8]
and were also identified in the submucosal plaque of pa-
tients with peri-implantitis [9,10]. These studies, how-
ever, mainly focused on the assessment of Candida
albicans, and at the time being, a qualitative evaluation
of other fungal organisms is lacking. Moreover, the po-
tential role of yeasts and their co-aggregation with either
periodontopathogens or other opportunistic bacteria at
peri-implantitis sites is unknown.
Therefore, the aim of the present study was to analyze
and correlate fungal organisms and bacterial species at
peri-implantitis and healthy implant sites as well as teethan open access article distributed under the terms of the Creative Commons
g/licenses/by/4.0) which permits unrestricted use, distribution, and reproduction
roperly credited.
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ase chain reaction (PCR).
Methods
Study population
A total of 29 partially or fully edentulous patients were
consecutively recruited from the Department of Oral
Surgery, Heinrich Heine University, Düsseldorf, Germany,
between April 2013 and July 2014. Nineteen patients
(7 men and 13 women; mean age 58.8 ± 12.6 years)
suffered from initial to moderate or advanced peri-
implantitis, while ten patients (6 men and 4 women; mean
age 55.2 ± 11.3 years) revealed clinically healthy implant
sites. Prior to participation, each patient was given a de-
tailed description of the procedure and was required to
sign informed consent forms. The study was in accord-
ance with the Helsinki Declaration of 2008 and the study
protocol was approved by the ethics committee of the
Heinrich Heine University.
Patient selection
For patient selection, the following inclusion criteria
were defined: 1) partially or fully edentulous, 2) presence
of one screw-type titanium implant either exhibiting
healthy (absence of bleeding on probing (BOP), probing
depth (PD) <4 mm) or established peri-implantitis (i.e.,
bleeding on probing with or without suppuration/pus,
pocketing, and radiographic bone loss - initial to moder-
ate: <50%/advanced: >50% of the implant length relative
to baseline) [11], 3) presence of a sufficiently dimen-
sioned (>2 mm) keratinized mucosa, 4) no implant mo-
bility, 5) no systemic antibiotic medication within the
last 3 months, 6) no history of malignancy, radiotherapy,
chemotherapy, or immunodeficiency within the last
4 years, 7) proper recall/periodontal maintenance care,
8) non-smoker or light smoking status in smokers (<10
cigarettes per day).
Plaque samples
After a gentle supramucosal cleaning, submucosal plaque
samples and peri-implant sulcus fluid were collected at the
deepest aspect of each implant site by means of sterile
paper points (i.e., each was left in place for 30 s). The paper
point was transferred into 200 μl G2 buffer of the EZ1
DNA Tissue Kit (Qiagen, Hilden, Germany) and stored at
−20°C until transportation to the Institute of Medical
Microbiology and Hospital Hygiene at the Heinrich Heine
University for analysis.
In the peri-implantitis group, one additional subgingi-
val plaque sample was obtained from partially edentu-
lous patients with a history of periodontitis (n = 10) and
obtained at a tooth exhibiting the highest PD but no
signs of acute periodontal disease (i.e., BOP/no suppur-
ation). None of these teeth were located adjacent to thesampled implant sites. The control samples were also
prepared for PCR analysis.
Genomic DNA preparation
At the Institute of Medical Microbiology and Hospital
Hygiene, the specimens were re-suspended in the buffer
by vortexing. After the addition of 10 μl Proteinase K so-
lution (100 μg/ml Proteinase K), the samples were incu-
bated for 30 min at 56°C. Total genomic DNA was
isolated from 200 μl of the Proteinase K-digested sam-
ples by semiautomatic DNA preparation on an EZ1 bior-
obot machine (Qiagen) and the eluted 100 μl DNA
samples stored at −20°C until use.
TaqMan PCR
In house TaqMan PCRs for the quantification of Myco-
plasma salivarium (M. salivarium) [12], Veillonella par-
vula (V. parvula) [13], S. aureus [14], P. gingivalis [15],
Parvimonas micra (P. micra) [16], and T. forsythia [15]
(Table 1) were carried out in a total volume of 25 μl con-
sisting of 1× Eurogentec qPCR MasterMix (Eurogentec,
Seraing, Belgium) without ROX (containing buffer, dNTPs
(including dUTP), HotGoldStar DNA polymerase, 5 mM
MgCl2, uracil-N-glycosylase and stabilizers (RT-QP2X-
03NR, Eurogentec)), 300 nM each forward and reverse
primer, 200 nM labeled probe, and 2.5 μl of template
DNA (primer and probes are listed in Tables 1 and 2).
Amplicon carrying plasmids were used in concentrations
of 105 and 102 copies/μl as quantification standards.
Thermal cycling conditions were as follows: 1 cycle at
50°C for 10 min, 1 cycle at 95°C for 10 min followed by
45 cycles at 95°C for 15 s, and 60°C for 1 min. Cycling
and fluorescent data collection and analysis were carried
out with an iCycler from BioRad (BioRad Laboratories,
Munich, Germany) according to the manufacturer’s
instructions.
Real-time PCR
Real-time PCR assays for the detection of fungal DNA
(Table 2) were carried out in a total volume of 25 μl
consisting of 1× MesaGreen qPCR MasterMix Plus
for SYBR Assay (containing Buffer, dNTPs (including
dUTP), Meteor Taq DNA polymerase, 4 mM MgCl2,
uracil-N-glycosylase, SYBR Green I, stabilizers and pas-
sive reference (RT-SY2X-06 +WOU); Eurogentec, Seraing,
Belgium), 300 nM each forward and reverse primer and
2.5 μl of template DNA. In multiplex assays with three
forward primers, each primer was adjusted to 100 mM.
Positive detection was verified by sequencing [17] and
BLAST analysis [18]. Thermal cycling conditions were
as follows: 10 min at 50°C, 10 min at 95°C followed by
40 cycles of 15 s at 95°C, and 1 min at 60°C. Subsequent
melting point analysis followed after 15 s at 95°C and
Table 1 Overview of bacterial species, corresponding genes, primers/probes, and DNA sequences
Species Gene Primer/probe Sequences (5′-3′)
Mycoplasma salivarium rpoB msali-F CCG TCA AAT GAT TTC GAT TGC
msali-R GAA CTG CTT GAC GTT GCA TGT T
msali-S Hex-ATG ATG CTA ACC GTG CGC TTA TGG GTG-BHQ1
Veillonella parvula 16S rDNA vpar-F TGC TAA TAC CGC ATA CGA TCT AAC C
vpar-R GCT TAT AAA TAG AGG CCA CCT TTC A
vpar-S HEX-CTA TCC TCG ATG CCG A-BHQ1
Staphylococcus aureus nuc saur-F CAA AGC ATC CTA AAA AAG GTG TAG AGA
saur-R TTC AAT TTT CTT TGC ATT TTC TAC CA
saur-S FAM-TTT TCG TAA ATG CAC TTG CTT CAG GAC CA-BHQ1
Porphyromonas gingivalis Arg-gingipain pgin-F CCT ACG TGT ACG GAC AGA GCT ATA
pgin-R AGG ATC GCT CAG CGT AGC ATT
pgin-S TexRed-TCG CCC GGG AAG AAC TTG TCT TCA-BHQ2
Parvimonas micra 16S rDNA pmic-F TCG AAC GTG ATT TTT GTG GAA A
pmic-R GGT AGG TTG CTC ACG TGT TAC TCA
pmic-S FAM-CCC GTT CGC CAC TT-BHQ1
Tannerella forsythia bspA tfor-F TCC CAA AGA CGC GGA TAT CA
tfor-R ACG GTC GCG ATG TCA TTG T
tfor-S FAM-CCG CGA CGT GAA ATG GTA TTC CTC-BHQ1
tfor-S II HEX-TCG CGA CGT GAA ATG GTA TTC CTC-BHQ1
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0.5°C for 15 s and plate read.
Statistical analysis
The statistical analysis was performed using a commer-
cially available software program (SPSS Statistics 22.0,
IBM Corp., Ehningen, Germany). Kendall-Tau-b correl-
ation coefficients were calculated to evaluate the de-
pendence between fungal organisms, bacterial species asTable 2 Overview of fungal organisms, corresponding genes,
Species Gene
Aspergillus spp. plus ITS2
Penicillium spp.
Rhizomucor spp. plus ITS2
Mucor spp. plus
Rhizopus spp.
Absidia spp. plus ITS2
Cunninghamella spp. plus
Lichtheimia spp.
Candida spp. ITS2well as disease severity (i.e., initial to moderate and ad-
vanced sites). Results were considered statistically sig-
nificant at P < 0.05.
Results
According to the given definition, the present analysis was
based on a total of n = 13 initial to moderate and n = 6
advanced peri-implantitis lesions (n = 19 patients), 10
healthy implant sites (n = 10 patients), as well as 10 teethprimers/probes, and DNA sequences
Primer/probe Sequences (5′-3′)
aspe-F CTG TCC GAG CGT CAT TG
pen1-F GTC CGA GCG TCA TTT CTG
pen2-F TCC GAG CGT CAT TGC TG
its2-R TCC TCC GCT TAT TGA TAT GC
muco-F GAA CGC AWC TTG CGC TCA
rhi1-F TCA TCC ATT GGG TAC GTC TAG
its2-R TCC TCC GCT TAT TGA TAT GC
absi-F ATY TTT GAA CGC ATC TTG CA
lic1-F ATT YAG TTG CTG TCA TGG CC
lic2-F CAT TCA GTT GCT CTC ATG GTC
its2-R TCC TCC GCT TAT TGA TAT GC
cand-F CCT GTT TGA GCG TCR TTT
its2-R TCC TCC GCT TAT TGA TAT GC
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suffering from peri-implantitis).
Fungal and bacterial analysis
The analysis of fungal organisms as well as of M. sali-
varium, V. parvula, S. aureus, P. gingivalis, P. micra,
and T. forsythia at peri-implantitis as well as healthy im-
plant and selected tooth sites is presented in Tables 3, 4,
and 5.
Peri-implantitis sites
Fungal organisms were identified in 31.6% (six sites) of
the patients and equally distributed between initial to
moderate (three sites) and advanced (two sites) peri-
implantitis sites. The respective plaque samples were
dominated (n = 3) by Candida spp. (i.e., C. albicans and
Candida boidinii) and at two sites co-colonized with
Penicillium spp. and Rhodotorula laryngis. Paelicomyces
spp. (67% homologous), Saccharomycetes (76% homolo-
gous), and Cladosporium cladosporioides were identified
at three sites (Table 3). The Kendall-Tau-b coefficients
failed to reveal any significant correlations between the
presence of fungal organisms and the proportions of M.
salivarium (−0.26), V. parvula (0.26), S. aureus (0.34),
and P. gingivalis (0.09) as well as disease severity (0.26)
(P > 0.05, respectively). However, a significant correlation
was noted with respect to the proportions of P. micra
(−0.42) and T. forsythia (−0.44) (P < 0.05, respectively).Table 3 Bacterial and fungal analysis: peri-implantitis sites (n
Patient Severity M. salivarium V. parvula S. aureus P. gin
1 i-m - 7.96E + 04 - -
2 i-m 3.31E + 02 4.59E + 03 - -
3 i-m 1.80E + 01 5.25E + 02 - 3.07E +
4 i-m 1.02E + 01 3.23E + 03 - 1.16E +
5 i-m - 2.08E + 03 - -
6 i-m 1.23E + 02 2.29E + 03 - 4.40E +
7 i-m 1.17E + 03 9.02E + 02 - 6.37E +
8 i-m - 3.13E + 03 - -
9 i-m - 1.13E + 02 - 7.67E +
10 i-m 1.46E + 04 5.58E + 04 - 1.24E +
11 i-m - 8.22E + 03 - -
12 i-m 1.48E-01 4.98E + 03 37.43 2.31E +
13 i-m 8.46E + 02 1.76E + 02 - -
14 a 1.66E + 03 3.90E + 04 - 1.28E +
15 a 1.91E + 02 1.13E + 03 - 1.51E +
16 a 1.29E + 05 1.27E + 04 - -
17 a 6.82E + 01 5.43E + 01 - -
18 a 1.95E + 04 1.35E + 05 - 1.46E +
19 a - 7.43E + 03 - 3.08E +
i-m, initial to moderate; a, advanced.Healthy implant sites
In the selected partially edentulous patients, fungal or-
ganisms were identified at four implant sites (Candida
dubliniensis and C. cladosporioides), corresponding to a
frequency of 40.0% (Table 4). The Kendall-Tau-b coeffi-
cients failed to reveal any significant correlations between
the presence of fungal organisms and the proportions of
M. salivarium (0.38),V. parvula (−0.24), S. aureus (−0.33),
and P. gingivalis (−0.51) (P > 0.05, respectively). However,
a significant correlation was noted with respect to the
proportions of P. micra (0.65) and T. forsythia (0.65)
(P < 0.05, respectively).
Selected tooth sites
In the selected partially edentulous patients, fungal or-
ganisms were identified at two tooth sites (C. albicans
and Fusarium solani), corresponding to a frequency of
20.0% (Table 5).
The Kendall-Tau-b coefficients failed to reveal any sig-
nificant correlations between the presence of fungal or-
ganisms and the proportions of M. salivarium (0.25), V.
parvula (0.34), P. gingivalis (0.60), P. micra (0.32), T. for-
sythia (0.12), and S. aureus (0.66) (P > 0.05, respectively).
Discussion
The present study aimed at analyzing and correlating
fungal organisms with several periodontopathogenic
and opportunistic bacterial species at peri-implantitis= 19 patients)
givalis P. micra T. forsythia Fungal organisms
6.29E + 01 2.14E + 01 Paelicomyces spp.
1.94E + 04 6.60E + 01 -
05 7.67E + 04 9.28E + 04 -
02 1.98E + 02 3.33E + 01 Candida boidinii, Penicillium spp.
1.11E + 01 1.51E + 01 -
04 1.45E + 03 1.33E + 04 -
03 3.71E + 03 4.28E + 01 -
- 3.87E + 00 Candida albicans
01 4.26E + 03 5.20E + 03 -
01 1.29E + 03 5.33E + 04 -
- 1.06E + 02 -
02 3.10E + 01 5.33E + 01 Cladosporium cladosporioides
1.33E + 04 2.99E + 03 -
05 6.75E + 03 1.02E + 04 Rhodotorula laryngis, Candida alb.
01 6.33E + 03 1.56E + 01
3.85E + 05 1.29E + 05 -
3.00E + 04 1.17E + 04 -
04 2.25E + 03 4.44E + 03 -
01 1.26E + 02 1.33E + 02 -
Table 4 Bacterial and fungal analysis: healthy implant sites (n = 10 patients)
Patient M. salivarium V. parvula S. aureus P. gingivalis P. micra T. forsythia Fungal organisms
1 - 2.26E + 03 - 1.64E + 01 8.02E + 00 7.58E + 01 -
2 1.46E + 04 3.94E + 04 36.45 - 4.00E + 04 1.14E + 04 Candida dubliniensis
3 - 3.16E + 04 37.49 1.62E + 01 8.88E + 01 4.90E + 01 -
4 - 3.42E + 04 - - 1.62E + 04 7.78E + 01 -
5 - 1.78E + 04 - - 1.81E + 02 3.66E + 03 -
6 - 2.74E + 03 - - 1.38E + 01 1.40E + 02 Cladosporium cladosporioides
7 - 2.50E + 02 36.90 - 1.03E + 03 6.19E + 01 -
8 9.34E + 01 1.37E + 03 36.61 8.52E + 02 1.15E + 03 2.84E + 01 -
9 2.04E + 01 1.29E + 03 - - 8.06E + 01 8.79E + 02 Cladosporium cladosporioides
10 - - - - 4.48E + 02 8.69E + 02 Cladosporium cladosporioides
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pared with those noted at healthy implant sites as well
as teeth with a history of periodontitis.
Basically, the present analysis has pointed to a high
prevalence of fungal organisms in submucosal plaque
samples obtained at both peri-implantitis (31.6%) and
healthy (40%) implant sites. Peri-implantitis sites were
dominated by Candida spp. (i.e., C. albicans and C.
boidinii) and occasionally co-colonized with Penicillium
spp. and R. laryngis, while at three additional sites,
Paelicomyces spp., Saccharomycetes, and C. cladospor-
ioides were identified. Healthy implant sites were mainly
associated with C. dubliniensis and C. cladosporioides.
In this context, it must be emphasized that this is the first
report on Penicillium spp., R. laryngis, Paelicomyces spp.,
Saccharomycetes, and C. cladosporioides at implant sites,
and therefore, any comparison with previous findings is not
feasible. However, the high proportions of Candida spp.
noted in the present analysis corroborate previous data also
pointing to a frequency of 55% at peri-implantitis sites [9],
while a most recent study merely identified C. albicans in
3% of the patients investigated [10].
In contrast to the present data, Leonhardt et al. failed
to identify Candida spp. in a total of 51 patients withTable 5 Bacterial and fungal analysis: tooth sites (n = 10 patie
Patient M. salivarium V. parvula S. aureus P. g
1 7.05E + 01 7.00E + 01 - -
5 - 1.18E + 04 - 6.30
6 4.08E + 03 6.71E + 02 - -
7 4.55E + 02 7.06E + 03 - 1.43
10 - 1.79E + 02 - 1.76
12 1.79E + 03 1.92E + 03 - -
13 - 1.26E + 02 - -
16 - 3.19E + 03 - 1.07
17 2.69E + 01 2.68E + 03 28.25 6.82
19 1.03E + 01 1.33E + 02 - -clinically healthy mucosal conditions [9]. In this context,
however, it is also important to emphasize that the pres-
ence of C. albicans per se does not necessarily cause
symptomatic oral mucosal lesions (i.e., stomatitis) [19].
Host susceptibility to these infections is commonly trig-
gered either by local or systemic (e.g., HIV infection,
antibiotic medication) factors [20,21]. Furthermore, Can-
dida spp. possess a high potential to colonize and invade
gingival tissues [22] and co-aggregate with other oral mi-
croorganisms such as Pg [23,24]. The present microbio-
logical analysis also has identified high proportions of
periodontopathogenic bacteria associated with peri-implant
diseases, thus corroborating previous analyses [4,7,9,25,26].
However, at both peri-implantitis and healthy implant sites,
fungal organisms were only correlated with P. micra and T.
forsythia. Unfortunately, the PCR analysis employed did
not allow for a quantification of yeasts, and therefore, fur-
ther studies are needed to determine relative differences in
the composition of these specific organisms at healthy and
diseased implant sites.
Furthermore, the present analysis failed to identify any
significant correlation of either fungal organisms or dis-
ease severity with opportunistic bacteria, such as M. sali-
varium, V. parvula, and S. aureus. At tooth sites, M.nts)
ingivalis P. micra T. forsythia Fungal organisms
- 4.67E + 01 -
E + 00 5.02E + 02 1.51E + 01 -
5.23E + 03 4.89E + 04 Fusarium solani
E + 05 1.47E + 04 6.36E + 04 -
E + 01 5.49E + 00 2.40E + 00 -
1.43E + 04 3.59E + 03 Candida albicans
- 1.21E + 02 -
E + 04 3.44E + 03 3.01E + 04 -
E + 01 2.08E + 02 4.83E + 01 -
9.81E + 01 4.08E + 01 -
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and associated with gingivitis lesions [27]. Interest-
ingly, S. aureus has only been identified at one single
peri-implantitis - but several healthy implant sites,
which is contradictory to the higher prevalence at peri-
implantitis sites noted in larger cohorts [4,7,9]. When
further analyzing the present data, it was also noted
that at several sites, the frequency of selected period-
ontopathogenic bacteria was below the detection thresh-
olds, irrespective of disease severity. These findings clearly
corroborate previous data indicating that these periodon-
topathogenic bacteria may not necessarily be related to
peri-implantitis [6].
Fungal organisms have also been isolated from peri-
odontal pockets in chronic periodontitis patients. The
reported prevalence of yeast-positive samples varied be-
tween 15.6% and 17.5% [28,29]. These untreated peri-
odontal pockets were also dominated by C. albicans.
Other species, such as Candida parapsilosis, C. dubli-
niensis, Candida tropicalis, and Rhodotorula spp., were
rarely observed [30]. Even though the prevalence of C.
albicans tended to be higher in chronic periodontitis
(30%) when compared with healthy patients (15%), this
difference did not reach statistical significance [30]. The
present frequency of fungal organisms in subgingival
plaque samples obtained from teeth with a history of
periodontitis basically corroborates the above reported
data but was markedly lower when compared with all
implant sites investigated. However, the frequency distri-
bution of periodontopathogenic and opportunistic bacteria
did not seem to differ between tooth and implant sites,
which is basically in line with a recent analysis assessing
Aggregatibacter actinomycetemcomitans, Pg, Prevotella
intermedia, Tf, Treponema denticola, S. aureus, enteric
bacteria, and P. aeruginosa [10]. In this context, it must
be emphasized that the present analysis just focused on
the most relevant periodontopathogens associated with
peri-implantitis [4] as well as a few opportunistic bacteria
[4,7,9,27] that were linked to the oral cavity. Therefore,
future analyses should consider a broader spectrum of
potential pathogens.Conclusions
Within the limitations of the present analysis, it was
concluded that Candida spp. and other fungal organ-
isms were frequently identified at peri-implantitis as well
as healthy implant sites and co-colonized with P. micra
and T. forsythia.Abbreviations
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